SARS-CoV-2 generates amyloid in cerebral spinal fluid
In a recent study posted to the bioRxiv* preprint server, an international team of researchers demonstrated amyloid aggregation due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human cerebrospinal fluid (CSF).
Source: news-medical.net